National Health Investors profit margin NHI
Gross, operating and net profit as a share of revenue over the last twelve months, from 2010.
- Net margin, 12 months
- 38.6%
- Net margin on a year earlier
- −2.4 pts
- Peer median
- 16.1%
Over the twelve months to Jun 30, 2026, National Health Investors kept 38.6% of its revenue as net profit.
Five years earlier its net margin was 48.1%.
The median for 10 specialty REITs of a similar size is 16.1%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin |
|---|---|
| FY2025 | 37.9% |
| FY2024 | 41.2% |
| FY2023 | 42.4% |
| FY2022 | 23.9% |
| FY2021 | 37.4% |
| FY2020 | 55.6% |
| FY2019 | 50.4% |
| FY2018 | 52.4% |
| FY2017 | 57.2% |
| FY2016 | 61.0% |
| FY2015 | 65.0% |
| FY2014 | 57.2% |
| FY2013 | 90.1% |
| FY2012 | 97.2% |
| FY2011 | 84.3% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year |
|---|---|---|---|
| Q2 FY26 | 38.6% | −2.4 pts | |
| Q1 FY26 | 36.9% | −4.3 pts | |
| Q4 FY25 | 37.9% | −3.3 pts | |
| Q3 FY25 | 41.4% | +2.9 pts | |
| Q2 FY25 | 41.0% | +1.9 pts | |
| Q1 FY25 | 41.2% | −0.3 pts | |
| Q4 FY24 | 41.2% | −1.2 pts | |
| Q3 FY24 | 38.6% | +4.6 pts | |
| Q2 FY24 | 39.1% | +3.1 pts | |
| Q1 FY24 | 41.4% | +9.4 pts | |
| Q4 FY23 | 42.4% | +18.5 pts | |
| Q3 FY23 | 33.9% | +8.3 pts |
Against its peers
Companies in REIT - Specialty nearest National Health Investors' size, closest first, today.
| Company | Profit margin |
|---|---|
| NHINational Health Investors | 38.6% |
| BNLBroadstone Net Lease | 30.6% |
| HIWHighwoods Properties | 20.8% |
| IRTIndependence Realty Trust | 6.5% |
| LXPLXP Industrial Trust | 18.7% |
| CXWCoreCivic | 5.1% |
| CDPCopt Defense Properties | 20.9% |
| DRHDiamondRock Hospitality | 13.5% |
| DXDynex Capital | n/m |
| HHHHoward Hughes | 12.3% |
| AKRAcadia Realty Trust | n/m |
| Peer median | 16.1% |
Where National Health Investors ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on National Health Investors
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.